PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
Kapo Saukkonen(Päijät-Hämeen Keskussairaala), Caj Haglund(University of Helsinki)
Cited by 43
Related Papers
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Prognostic Values of Tissue and Serum Angiogenic Growth Factors Depend on the Phenotypic Subtypes of Colorectal Cancer
|Cancers|2023|4
Solid tumor growth depends on an intricate equilibrium of malignant cell states
|bioRxiv (Cold Spring Harbor Laboratory)|2023|3